Aclaris Therapeutics, Inc. — SC 13G/A Filings
58 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Aclaris Therapeutics, Inc. (ACRS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aclaris Therapeutics, Inc. has filed 58 SC 13G/A documents with the SEC since 2012. To view all SEC filings by Aclaris Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001104659-24-118918 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001273087-24-000095 | Oct 9, 2024 | — |
| SC 13G/A | — | 0001086364-24-008117 | Jul 8, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024206 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023983 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023946 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-002856 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-001203 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-24-000465 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-019725 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001616824-24-000044 | Feb 8, 2024 | — |
| SC 13G/A | — | 0001273087-24-000032 | Feb 1, 2024 | — |
| SC 13G/A | — | 0001086364-24-003766 | Jan 25, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000936872-23-000008 | Dec 11, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-23-000018 | Apr 10, 2023 | — |
| SC 13G/A | — | 0001172661-23-001243 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000520 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-019848 | Feb 13, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000065 | Feb 6, 2023 | — |
| SC 13G/A | — | 0001306550-23-005155 | Jan 31, 2023 | — |
| SC 13G/A | — | 0001172661-22-000960 | Feb 15, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-020374 | Feb 11, 2022 | — |
| SC 13G/A | — | 0001037389-22-000001 | Feb 10, 2022 | — |
| SC 13G/A | ACLARIS THERAPEUTICS, INC. | 0000902664-22-001327 | Feb 10, 2022 | — |
| SC 13G/A | — | 0001172661-21-000752 | Feb 16, 2021 | — |
| SC 13G/A | — | 0000935836-21-000099 | Feb 12, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-020580 | Feb 11, 2021 | — |
| SC 13G/A | ACLARIS THERAPEUTICS, INC. | 0000902664-21-001114 | Feb 11, 2021 | — |
| SC 13G/A | — | 0001037389-21-000160 | Feb 11, 2021 | — |
| SC 13G/A | SCH 13G/A FILING FOR MFN PARTNERS (FILER) AND ISSUER ACLARIS, TO BE FILED IN JUL | 0000904454-20-000503 | Jul 22, 2020 | — |
| SC 13G/A | — | 0000834237-20-009989 | Jul 10, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-021847 | Feb 14, 2020 | — |
| SC 13G/A | — | 0001172661-20-000734 | Feb 14, 2020 | — |
| SC 13G/A | — | 0000919574-20-001125 | Feb 13, 2020 | — |
| SC 13G/A | SCH 13G/A FILING FOR MFN PARTNERS (FILER) AND ISSUER ACLARIS, TO BE FILED IN FEB | 0000904454-20-000171 | Feb 13, 2020 | — |
| SC 13G/A | — | 0001193805-20-000193 | Feb 13, 2020 | — |
| SC 13G/A | — | 0000905148-20-000306 | Feb 10, 2020 | — |
| SC 13G/A | — | 0000315066-20-000819 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000834237-20-004757 | Feb 5, 2020 | — |
| SC 13G/A | — | 0001193805-19-000689 | Jul 31, 2019 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001144204-19-008093 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000315066-19-000849 | Feb 13, 2019 | — |
| SC 13G/A | — | 0001193805-19-000181 | Feb 12, 2019 | — |
| SC 13G/A | — | 0000215457-19-003192 | Feb 4, 2019 | — |
| SC 13G/A | — | 0000315066-18-002537 | Dec 10, 2018 | — |
| SC 13G/A | — | 0001193805-18-001270 | Oct 24, 2018 | — |
| SC 13G/A | — | 0000315066-18-002071 | Jul 10, 2018 | — |
| SC 13G/A | — | 0000315066-18-001759 | Mar 12, 2018 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001193125-18-045269 | Feb 14, 2018 | — |
| SC 13G/A | — | 0001193805-18-000193 | Feb 14, 2018 | — |